Why is Amerise BioScie falling/rising?

As of 15-Oct, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at Rs. 0.61, which reflects a decrease of Rs. 0.01 or 1.61%. The stock has hit a new 52-week low today and has been on a downward trend, having fallen consecutively for the last four days, resulting in a total decline of 6.15% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating persistent weakness. Furthermore, investor participation has decreased, with delivery volume dropping by 26.6% compared to the 5-day average, suggesting a lack of interest or confidence among investors.
In the broader market context, the Sensex has shown a positive return of 1.02% over the past week, contrasting sharply with Amerise Biosciences' 6.15% decline during the same period. This underperformance is further highlighted by the fact that the finance/NBFC sector has gained 2.16%, indicating that while the market is generally moving upward, Amerise is lagging significantly behind. The stock's year-to-date performance is particularly concerning, with a decline of 49.59%, while the benchmark has risen by 5.72%, underscoring the challenges faced by Amerise in attracting investor interest amidst a recovering market.